Virtual
May 19–21, 2021

Past Forum: 2020

Virtual

Summary

The sixth annual World Medical Innovation Forum took place in the extraordinary environment of a world-wide pandemic that has altered medicine, the delivery of care to patients, and the way we live. This virtual meeting explored the technologies driving the response to the coronavirus, how medicine is being reinvented real time and how the urgency of today will take root in the future. In 18 virtually broadcast sessions, Mass General Brigham’s Harvard faculty, industry experts and leading investors jointly reflect on the technologies and challenges defining this historic era in health care. The World Medical Innovation Forum was established to reaffirm the importance of collaborative innovation—academia, industry and government working together to create solutions to medicine’s great challenges. Our goal is to provide actionable insights for Forum participants. We are grateful to the 60 senior executives, investors, Harvard clinicians and investigators who will share their insights as speakers.

Keynoters

General Keith Alexander  

  • Co-CEO, IronNet Cybersecurity

Albert Bourla, PhD  

  • CEO, Pfizer Inc.

Karen DeSalvo, MD  

  • Chief Health Officer, Google Health

Anne Heatherington, PhD  

  • SVP, Head of Data Sciences Institute, Takeda

Patricia Hurter, PhD  

  • CEO, Lyndra Therapeutics

Anne Klibanski, MD  

  • CEO, Mass General Brigham

Rachel Kohler  

  • CEO, NowPow

Nick Leschly  

  • Chief Bluebird, Bluebird Bio

Mike Mahoney  

  • CEO, Boston Scientific

Bernd Montag, PhD  

  • CEO, Siemens Healthineers

Kieran Murphy  

  • CEO, GE Healthcare

Amir Dan Rubin  

  • CEO, One Medical

Panels

Monday, May 11, 2020

Opening Remarks

  • Introduction: Scott Sperling, Co-President, Thomas H. Lee Partners; Chairman of the Board of Directors, Mass General Brigham 
  • Anne Klibanski, MD, President & CEO, Mass General Brigham

Care in the Next 18 Months – Routine, Elective, Remote

  • Moderator: Gregg Meyer, MD, Chief Clinical Officer, Mass General Brigham; Interim President, NWH; Professor of Medicine, HMS
  • John Fernandez, President, Mass Eye and Ear and Mass General Brigham Ambulatory Care
  • Elizabeth Nabel, MD, President, Brigham Health; Professor of Medicine, HMS
  • Peter Slavin, MD, President, MGH; Professor, Health Care Policy, HMS

COVID-19: Technology Solutions Now and in the Future

  • Moderator: Alice Park, Senior Writer, Time
  • Stephane Bancel, CEO, Moderna
  • Paul Biddinger, MD, Medical Director for Emergency Preparedness, MGH; Associate Professor of Emergency Medicine, HMS
  • David Kaufman, MD, PhD, Head of Translational Development, Bill & Melinda Gates Medical Research Institute
  • Rochelle Walensky, MD, Chief, Infectious Disease, Steve and Deborah Gorlin MGH Research Scholar, MGH; Professor of Medicine, HMS

Digital Health Becomes a Pillar: Tools, Payment, Data

  • Moderator: David Louis, MD, Pathologist-in-Chief, MGH; Benjamin Castleman Professor of Pathology, HMS
  • Alistair Erskine, MD, Chief Digital Health Officer, Mass General Brigham
  • Adam Landman, MD, VP, Chief Information and Digital Innovation Officer, BH; Associate Professor of Emergency Medicine, HMS
  • Brooke LeVasseur, CEO, AristaMD
  • Lee Schwamm, MD, Director, Center for TeleHealth and Exec Vice Chair, Neurology, MGH; Vice President, Virtual Care/Digital Health, Mass General Brigham; Professor, Neurology, HMS

1:1 Fireside Chat: Bayer Pharma Reflections on Innovation: Creating, Collaborating, and Accelerating Discovery During and After a Pandemic

  • Introduction: John Fish, CEO, Suffolk; Chairman of Board Trustees, Brigham Health
  • Moderator: Janet Wu, Bloomberg
  • Joerg Moeller, MD, PhD, Head of Research & Development, Pharmaceuticals Division, Bayer AG

The Patient Experience During the Pandemic

  • Moderator: Thomas Sequist, MD, Chief Patient Experience and Equity Officer, Mass General Brigham; Professor of Medicine and Health Care Policy, HMS
  • Anjali Kataria, CEO, Mytonomy
  • Daniel Kuritzkes, MD, Chief, Division of Infectious Diseases, BH; Harriet Ryan Albee Professor of Medicine, HMS
  • Peter Lee, PhD, Corporate Vice President, Microsoft Research and Incubation
  • Jag Singh, MD, PhD, Cardiologist & Founding Director, Resynchronization and Advanced Cardiac Therapeutics Program, MGH; Professor of Medicine, HMS

The Role of AI and Big Data in Fighting COVID-19 and the Next Global Crisis – Successes and Aspirations

  • Moderator: Alice Park, Senior Writer, Time
  • Mike Devoy, MD, EVP, Medical Affairs & Pharmacovigilance and CMO, Bayer AG
  • Karen DeSalvo, MD, Chief Health Officer, Google Health
  • Keith Dreyer, DO, PhD, Chief Data Science Officer, Mass General Brigham; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS

Designing for Infection Prevention: Innovation and Investment in Personal Protective Equipment and Facility Design

  • Moderator: Erica Shenoy, MD, PhD, Associate Chief, Infection Control Unit, MGH; Assistant Professor, HMS
  • Shelly Anderson, SVP, Strategic Initiatives and Partnerships, & Chief Strategy Officer, BH
  • Michele Holcomb, PhD, EVP, Strategy and Corporate Development, Cardinal Health
  • Guillermo Tearney, MD, PhD, Remondi Family Endowed MGH Research Institute Chair, Mike and Sue Hazard MGH Research Scholar, MGH; Professor, Pathology, HMS
  • Teresa Wilson, Director/Architect, Colliers Project Leaders

1:1 Fireside Chat: Preparing for Fall 2020 and Beyond: Production, Innovation, Optimization 

  • Introduction: Jonathan Kraft, President, The Kraft Group; Chair, Mass General Hospital Board of Trustees
  • Moderator: Timothy Ferris, MD, CEO, MGPO; Professor, HMS
  • Kieran Murphy, CEO, GE Healthcare

Big Tech and Digital Health

  • Moderator: Natasha Singer, Reporter, New York Times
  • Amanda Goltz, Principal, Business Development, Alexa Health & Wellness, Amazon
  • Michael Mina, MD, PhD, Associate Medical Director, Molecular Virology, BH; Assistant Professor, Epidemiology, Immunology and Infectious Diseases, Harvard Chan School
  • Marcus Osborne, VP, Walmart Health, Walmart
  • Jim Weinstein, MD, SVP, Microsoft

1:1 Fireside Chat: Insights on Pandemics and Health Care from the National Security Community

  • Moderator: Gregg Meyer, MD, Chief Clinical Officer, Mass General Brigham; Interim President, NWH; Professor of Medicine, HMS
  • General (Ret) Keith Alexander, Co-CEO, IronNet Cybersecurity

Calibrating Innovation Opportunity and Urgency: Medical and Social

  • Moderator: Natasha Singer, Reporter, New York Times
  • Giles Boland, MD, Chair, Department of Radiology, BH; Philip H. Cook Professor of Radiology, HMS
  • Amit Phadnis, Chief Digital Officer and GE Company Officer, GE Healthcare
  • Krishna Yeshwant, MD, General Partner, GV; Instructor in Medicine, BH

FDA Role in Managing Crisis and Anticipating the Next

  • Moderator: Ravi Thadhani, MD, CAO, Mass General Brigham; Professor of Medicine and Faculty Dean for Academic Programs, HMS
  • Amy Abernethy, MD, PhD, Principal Deputy Commissioner & Acting CIO, FDA
  • Lindsey Baden, MD, Director, Clinical Research, Division of Infectious Diseases, BH; Associate Professor, HMS

1:1 Fireside Chat: Keeping Priority on the Biggest Diseases

  • Moderator: Jean-François Formela, MD, Partner, Atlas Venture
  • Michel Vounatsos, CEO, Biogen

Building the Plane While Flying: The Experience of Real-Time Innovation from the Front Line

  • Moderator: Ann Prestipino, SVP; Incident Commander, MGH; Teaching Associate, HMS
  • Theresa Gallivan, RN, Associate Chief Nurse, MGH
  • Karen Reilly, DNP, RN, Associate Chief Nursing Officer, Critical Care, Cardiovascular and Surgical Services, BH
  • Ross Zafonte, DO, SVP, Research Education and Medical Affairs, SRN; Earle P. and Ida S. Charlton Professor of Physical Medicine and Rehabilitation, HMS

CEO Roundtable: Will the Innovation Model Remain as It Was

  • Moderator: Janet Wu, Bloomberg
  • Mike Mahoney, CEO, Boston Scientific
  • Bernd Montag, PhD, CEO, Siemens Healthineers

Emergency and Urgent Care: How COVID-19 Vulnerabilities and Solutions Will Change the Model

  • Moderator: Ron Walls, MD, EVP and Chief Operating Officer, BH; Neskey Family Professor of Emergency Medicine, HMS
    Troyen Brennan, MD, EVP and CMO, CVS Health
  • David Brown, MD, Chair, Department of Emergency Medicine, MGH; MGH Trustees Professor of Emergency Medicine, HMS
  • Julie Lankiewicz, Head, Clinical Affairs & Health Economics Outcomes Research, Bose Health
  • Michael VanRooyen, MD, Chairman, Department of Emergency Medicine, BH; Director, Humanitarian Initiative, Harvard University; Professor, HMS

Accelerating Diagnostics – Maintaining the Priority: Lab, Home and Digital

  • Moderator: Jeffrey Golden, MD, Chair, Department of Pathology, BH; Ramzi S. Cotran Professor of Pathology, HMS
  • James Brink, MD, Chief, Department of Radiology, MGH; Juan M. Taveras Professor of Radiology, HMS
  • John Iafrate, MD, PhD, Vice Chair, Academic Affairs, MGH; Professor, Pathology, HMS
  • Celine Roger-Dalbert, VP Diagnostic Assays R&D – Integrated Diagnostic Solutions, BD Life Sciences
  • Matt Sause, President and CEO, Roche Diagnostics Corporation

1:1 Fireside Chat: Return to Work: Understanding the Technologies and Strategies

  • Moderator: Peter Markell, EVP, Finance and Administration, CFO & Treasurer, Mass General Brigham
  • Marc Casper, Chairman, President and CEO, Thermo Fisher Scientific

Digital Therapeutics: Current and Future Opportunities

  • Moderator: Hadine Joffe, MD, Vice Chair for Research, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women’s Health and Gender Biology, BH; Paula A. Johnson Professor, Women’s Health, HMS
  • Priya Abani, CEO, AliveCor
  • Julia Hu, CEO, Lark Health
  • Dawn Sugarman, PhD, Assistant Psychologist, Division of Alcohol, Drugs, and Addiction, McLean; Assistant Professor, Psychiatry, HMS

Investing During and After the Coronavirus Crisis

  • Moderator: Roger Kitterman, VP, Venture and Managing Partner, Partners Innovation Fund, Mass General Brigham
  • Jan Garfinkle, Founder & Manager Partner, Arboretum Ventures
    Phillip Gross, Managing Director, Adage Capital Management
  • Christopher Viehbacher, Managing Partner, Gurnet Point Capital

Closing Remarks

  • Gregg Meyer, MD, Chief Clinical Officer, Mass General Brigham; Interim President, NWH; Professor of Medicine, HMS
  • Ravi Thadhani, MD, CAO, Mass General Brigham; Professor of Medicine and Faculty Dean for Academic Programs, HMS

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA